DemocratBill · S. 4109· Senate(119-S-4109)

Stem Cell Therapeutic and Research Reauthorization Act of 2026

Rep. Reed
Age: 77 years
Rhode Island
Introduced
3/17/2026
Last activity
6/22/2026 — Placed on Senate Legislative Calendar under General Orders. Calendar No. 443.
Sponsored by
John Reed
Cosponsors
Democrat - 1Republican - 2
Health
  1. Introduced
  2. On Calendar

What this bill would do

This bill, known as the Stem Cell Therapeutic and Research Reauthorization Act of 2026, extends and updates the Stem Cell Therapeutic and Research Act of 2005. It provides funding for the C.W. Bill Young Cell Transplantation Program through 2031. The bill changes how the National Cord Blood Inventory is managed, moving from a specific unit goal to a "sufficient supply" as determined by the Secretary. It also allows the Secretary to transfer units from non-operational or non-compliant banks to other qualified entities. Additionally, it requires periodic reviews of the state of science regarding high-quality cord blood units and emergent technologies.

Yes· 3 of 19

  • Does this put more money into medical research?+8

    Provides significant funding and mandates reviews of the state of science regarding stem cell technology.

  • Does this put more money into scientific research?+8

    Reauthorizes funding for stem cell research and requires periodic scientific reviews.

  • Does this make health care easier to get in general?+7

    Increases availability and funding for high-quality cord blood units used in life-saving transplantations.

The opposite

  • Does this reduce what the federal government owes?-1

    The bill allocates additional federal spending for the C.W. Bill Young Cell Transplantation Program through 2031.

  • Does this reduce what the federal government spends?-1

    The bill increases funding for stem cell research and transplantation programs.